Neurocrine Biosciences, Inc. · NASDAQ:NBIX
Benevich Eric sold 2,154 Neurocrine Biosciences, Inc. shares (Form 4)
Traded Sep 9, 2026 · Filed Sep 10, 2026
On Sep 9, 2026, Benevich Eric (Chief Commercial Officer) sold 2,154 Neurocrine Biosciences, Inc. shares at US$154.61 for US$333K under a trading plan, leaving 64,408 shares. Filed Sep 10, 2026 (Form 4).
- Sold
- 2,154 shares
- Price
- US$154.61
- Value
- US$333K
- Holding after
- 64,408 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 9, 2026 | Common Stock | Option exercise | 3,194 | US$43.24 | 66,562 | Direct |
| Sep 9, 2026 | Common Stock | Sale | 2,154 | US$154.61 | 64,408 | Direct |
Source
Related
- Neurocrine Biosciences, Inc.
- Benevich Eric
- Neurocrine Biosciences, Inc. shareholders
- Form 4 · Benevich Eric · Sep 15, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 15, 2026
- Form 4 · Boyer David W. · Sep 15, 2026
- Form 4 · Abernethy Matt · Sep 15, 2026
- Form 4 · Gano Kyle · Sep 15, 2026
- Form 4 · Onyia Jude · Sep 15, 2026